Luna Bioscience, Inc.
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- Diagnostics
Luna Bioscience advances microbial genomics and diverse delivery platforms for vaccines, diagnostics, and therapeutics for infectious diseases. Leptospirosis, a globally important, devastating infection caused by spirochetes of the genus, Leptospira, which affects humans and animals (dogs and livestock) is our first focus and low-hanging fruit.
Antigen identified, dog safety and immunogenicity trial completed
We have identified novel antigens, with protected IP, that mediate vaccine protection from leptospira. We are now moving to pivotal dog trials and IND for Phase 1 human clinical trial.
Vaccine for infectious diseases along with diagnostic test in an integrated package.
Address
New HavenConnecticut
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}